ArticleFrontiers in medicine2026
Case Report: Image-enhanced endoscopic characteristics of gastric amyloidosis with narrow-band imaging comparison.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastrointestinal (GI) amyloidosis is a rare disorder with nonspecific clinical and endoscopic features, often leading to misdiagnosis. Timely recognition is crucial to prevent diagnostic delays and systemic complications. Case Presentation: A 64-year-old male initially presented with upper respiratory symptoms, and chest computed tomography (CT) performed for pneumonia evaluation incidentally revealed esophageal wall thickening. The first endoscopy showed diffuse redness with loss of the regular arrangement of collecting venules in the gastric body, and the findings were initially interpreted as Helicobacter pylori-associated gastritis. However, both gastric histopathology and the ¹³C urea breath test were negative, and no clear cause of erythema was identified. The patient's symptoms resolved after taking anti-inflammatory medication, and he did not return for follow-up as instructed. One year later, the patient developed proteinuria and bilateral lower extremity edema and was diagnosed with systemic light-chain (AL) amyloidosis involving the kidneys and heart. Repeat endoscopy revealed disc- and linear-shaped gastric erythema with a submucosal tumor (SMT)-like protrusion. Congo red staining with polarized light confirmed amyloid deposition in the gastric biopsy. In addition, we compared the endoscopic features of gastric erythema from three different etiologies. On narrow-band imaging (NBI), amyloid-related erythema showed a grayish-green signal with a more layered, deeper-appearing distribution, whereas vonoprazan-associated and Helicobacter pylori-associated erythema appeared more superficial with limited layering. Because absolute color intensity is not consistently comparable across panels, this observation should be considered hypothesis-generating rather than diagnostic. Conclusion: This case highlights the diverse and potentially misleading endoscopic manifestations of GI amyloidosis. NBI may aid in visualizing the distribution pattern and apparent depth of amyloid-related mucosal signals and serve as a supportive diagnostic tool; however, histological confirmation via Congo red staining remains the gold standard. The combination of image-enhanced endoscopy, targeted biopsies, and multidisciplinary evaluation may facilitate earlier recognition and more comprehensive management of patients with atypical gastric erythema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.